We have demonstrated that S100A2 levels are low in the A375(DRO) melanoma cell line, and these levels are increased by treatment with PPARγ and RXR agonists, which is associated with a significant reduction in growth and increase in apoptosis [8]. This evidence concerns the gene S100A2 and melanoma.